Sarepta therapeutics announces u.s. fda acceptance of an efficacy supplement to expand the elevidys indication

Cambridge, mass.--(business wire)--the u.s. fda accepted and filed an efficacy supplement to expand the elevidys indication.

SRPT Ratings Summary

SRPT Quant Ranking